Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.
Annie K Ting1, Yongjun Chen, Lei Wen
1Institute of Molecular Medicine and Genetics and Department of Neurology, Medical College of Georgia, Augusta, Georgia 30912, USA.
Summary
Neuregulin 1 (NRG1) plays a key role in excitatory synapse development in GABAergic interneurons, potentially impacting schizophrenia pathology. This study reveals NRG1’s specific synaptogenic effects, offering new insights into brain function.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuregulin 1 (NRG1) and ErbB4 are implicated in schizophrenia susceptibility.
- The precise mechanisms of NRG1's function in GABAergic interneurons are not well understood.
- ErbB4 is known to be enriched in GABAergic interneurons.
Purpose of the Study:
- To investigate the role of Neuregulin 1 (NRG1) in excitatory synapse formation in GABAergic interneurons.
- To elucidate the underlying mechanisms of NRG1 and ErbB4 malfunction in the context of schizophrenia.
- To determine if NRG1's synaptogenic effects are specific to GABAergic neurons.
Main Methods:
- In vitro electrophysiology to measure miniature EPSCs (mEPSCs) in response to NRG1 treatment.
- Immunohistochemistry to quantify synapse number and size (PSD-95 puncta).
- In vivo studies involving the deletion of ErbB4 in parvalbumin-positive interneurons.
Main Results:
- NRG1 significantly increased the number and size of excitatory synapses in GABAergic interneurons.
- NRG1 treatment enhanced the frequency and amplitude of mEPSCs in these neurons.
- NRG1's synaptogenic effect was specific to GABAergic interneurons and required ErbB4 tyrosine kinase activity.
- In vivo deletion of ErbB4 in interneurons reduced mEPSC frequency and amplitude.
Conclusions:
- NRG1 has a novel synaptogenic role in excitatory synapse development, specifically in GABAergic interneurons.
- NRG1 may stabilize excitatory synapses by affecting PSD-95, mediated through ErbB4.
- These findings provide potential insights into the pathophysiology of schizophrenia, linking NRG1/ErbB4 genes to GABAergic dysfunction.
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:04Glial Cells
Overview